| Literature DB >> 11734059 |
V Hampl1, S Vanácová, J Kulda, J Flegr.
Abstract
BACKGROUND: Despite the medical importance of trichomoniasis, little is known about the genetic relatedness of Trichomonas vaginalis strains with similar biological characteristics. Furthermore, the distribution of endobionts such as mycoplasmas or Trichomonas vaginalis virus (TVV) in the T. vaginalis metapopulation is poorly characterised.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11734059 PMCID: PMC60492 DOI: 10.1186/1471-2148-1-11
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
Figure 1The genealogical tree for 20 strains of Trichomonas vaginalis. The tree was constructed by Neighbor-joining method and rooted with representatives of other trichomonadid genera. The branch lengths reflect the genetic distances between the strains. The numbers show the bootstrap values (in percent) for every branch of the tree. The geographical origins and the values of minimal lethal concentration (MLC) for metronidazole (μg.ml-1) are listed for every strain. MLC values printed in red designate the strains, which were refractory to standard metronidazole treatment. The names of strains printed in blue designate strains infected with TVV. The apical branches printed in green designate strains infected with mycoplasmas.
Information on the origin of strains included in the analysis
| Species | Strain | Host | Origin | Isolation |
| TV 10–02 | Prague, Czech Rep. | Kulda, 1973 [ | ||
| TV 73–87 | Prague, Czech Rep. | Kulda, 1973 | ||
| TV 71–96 | Prague, Czech Rep. | Kulda, 1973 | ||
| TV 79–49 | Prague, Czech Rep. | Kulda, 1973 | ||
| TV 7–37 | Prague, Czech Rep. | Kulda, 1973 | ||
| TV 85–08 | Prague, Czech Rep. | Kulda, 1973 | ||
| TV 14–85 | Prague, Czech Rep. | Kulda, 1973 [ | ||
| TV 67–77 | Prague, Czech Rep. | Kulda, 1973 [ | ||
| TV 17–48 | Prague, Czech Rep. | Kulda, 1973 [ | ||
| HL-4MT | Liberec, Czech Rep. | Temín, 1986 | ||
| FF28 | Bratislava, Slovakia | Demeš, 1987 | ||
| C:1-NIH (ATCC 30001) | Washington, D.C., USA | Jacobs, 1956 [ | ||
| JH31A (ATCC 30236) | Baltimore, USA | Hollander, 1963 [ | ||
| CP1 | Peking, China | Tachezy, 1987 | ||
| JTCRYO | Rio de Janeiro, Brazil | SilvaFilho, 1982 [ | ||
| CDC-85 (ATCC 50143) | Columbus, USA | Lossick, 1980 [ | ||
| RU357 (ATCC 50139) | Pennsylvania, USA | Sondheimer, 1982 [ | ||
| TALL-MT | Tallin, Estonia | Tompel, 1987 | ||
| BO | Gothenburg, Sweden | Forsgren, 1978 [ | ||
| IR78 | Vienna, Austria | Meingassner, 1978 [ | ||
| TGK | Prague, Czech Rep. | Tachezy, 1994 | ||
| KVc-1 | Žalmanov, Czech Rep. | Lípová, 1962 [ | ||
| PHG-2 | Košice, Slovak Republic | Giboda, 1981 | ||
| BUB | Veselí nad Lužnicí, Czech Rep. | Kulda, 1983 | ||
| L3 (ATCC 30069) | California, USA | Honigberg, 1948 | ||
| M3 | Uhlířské Janovice, Czech Rep. | Suchánková, Kulda, 1970 [ |
* KVc-1 clone obtained from the original stock KV isolated by Lípová 1962 by double serial cloning.
The presence of TVV and mycoplasmas in analysed strains of Trichomonas vaginalis and their susceptibility to metronidazole.
| Strain | TVV | mycoplasmas | Patient response to treatment | MLC at 48 hours (metronidazole μg.ml-1)* (aerobic conditions) | ||
| Geometric mean | Range | n | ||||
| IR78 | - | - | Refractory | 107.2 | 50–200 | 20 |
| TV 79–49 | + | - | Cured | 1.92 | 1.56–6.5 | 10 |
| TV 71–96 | + | + | Cured | 3.35 | 3.125–6.25 | 10 |
| FF28 | + | - | Cured | 2.14 | 1.56–3.125 | 11 |
| TALL-MT | - | - | Refractory | 3.125 | 3.125 | 10 |
| CP1 | - | - | Cured | 2.01 | 0.78–6.25 | 11 |
| JH31A | - | - | Cured | 3.85 | 1.56–6.25 | 11 |
| C-1:NIH | + | - | Cured | 1.56 | 1.56 | 6 |
| JTCRYO | - | - | Cured | 2.50 | 1.56–3.125 | 6 |
| TV 10–02 | + | + | Cured | 4.7 | 3.125–12.5 | 36 |
| TV 14–85 | - | + | Cured | 9.9 | 6.25–12.5 | 36 |
| TV 73–87 | + | + | Cured | 3.12 | 3.12 | 12 |
| TV 67–77 | - | + | Cured | 12.5 | 12.5 | 12 |
| TV 85–08 | + | - | Cured | 6.25 | 6.25 | 12 |
| BO | + | - | Refractory | 50 | 50 | 12 |
| HL-4MT | - | - | Refractory | 317.5 | 200–400 | 36 |
| TV 7–37 | - | - | Cured | 20.83 | 12.5–25 | 36 |
| CDC-85 | - | - | Refractory† | 1000† | not available | not available |
| TV 17–48 | - | - | Cured | 12.5 | 12.5 | 3 |
| RU357 | - | - | Refractory† | 200 † | not available | not available |
* Minimal lethal concentrations (MLC) for metronidazole were determined by in vitro microtitre plate assay [32] under aerobic conditions. MLC was defined as the lowest concentration of metronidazole at which no motile parasites were detectable by microscopy. † Drug-susceptibility data for strains CDC-85 and RU 357 were obtained from literature [34].
Virulence of analysed Trichomonas vaginalis strains assessed on the basis of clinical findings, histopathological examination of ectocervical biopsies and results of mouse assays after intraperitoneal and subcutaneous inoculation.
| Intraperitoneal mouse test | Subcutaneous mouse test | Patients(d) | |||||
| Strain | Mortality % (a) | Virulence index (b) | N | Abscess volume (mm3) (c) | N | Symptoms | Histopathology |
| TV 85–08 | 50 | 7.7 | 20 | 132 | 38 | 2 | 2 |
| TV 73–87 | 43 | 10.4 | 30 | 66 | 31 | 2 | 2 |
| TV 71–96 | 24 | 6.0 | 37 | 121 | 38 | 2 | 3 |
| TV 79–49 | 73 | 10.7 | 30 | 176 | 65 | 1 | 1 |
| TV 14–85 | 86 | 10.8 | 30 | 127 | 29 | 4 | 3 |
| TV 67–77 | 47 | 8.7 | 30 | 63 | 40 | 2 | 2 |
| TV 10–02 | 0 | 3.7 | 20 | 79 | 37 | 1 | 1 |
| TV 7–37 | 90 | 13.4 | 30 | 230 | 41 | 4 | 4 |
| FF28 | 75 | 7.6 | 12 | 117 | 28 | 0 | nd |
| JH-31A | nd | nd | nd | 78.6 | 49 | 0 | 0 |
| TV 17–48 | 83 | 11.1 | 30 | 183 | 58 | 4 | 4 |
(a) Percent of inoculated mice that died within three weeks after inoculation. (b) Virulence index of Cavier et al.[23] ranges from 0 (avirulent) to 16 (maximum virulence). (c) Mean volumes of subcutaneous abscesses developed six days after inoculation. (d) Clinical and pathological changes found at gynaecological and histopathological examination rated according to increasing severity from 1 to 4 as indicated in reference [2].
Figure 2Distribution of MLC values for metronidazole tested under aerobic condition for different strains of T. vaginalis.